Methods of modulating inflammation in preterm infants using carotenoids

摘要

The present disclosure relates to preterm infant formulas comprising lutein, lycopene, and beta-carotene, and the use of the preterm infant formulas to modulate inflammation, such as skin inflammation, in preterm infants. Also disclosed are methods of modulating the level of C-reactive protein in a preterm infant using preterm infant formulas comprising mixtures of carotenoids.

主权项

1. A method of modulating inflammation in an infant having inflammation characterized by an elevated plasma level of C-reactive protein, the method comprising:
administering to the infant having inflammation characterized by an elevated plasma level of C-reactive protein a preterm infant formula comprising about 75 μg/L to about 500 μg/L of lutein, about 60 μg/L to about 500 μg/L of lycopene, and about 85 μg/L to about 500 μg/L of beta-carotene.